These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10104831)

  • 21. Whatever happened to expanded access?
    Notes Undergr; 1997; (No 35):2-3. PubMed ID: 11364564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AIDS drugs in development. Facts and comparisons.
    Hosp Pharm; 1993 Feb; 28(2):161, 165-7. PubMed ID: 10125704
    [No Abstract]   [Full Text] [Related]  

  • 23. AIDS drugs. DDI nears approval.
    Aldhous P
    Nature; 1991 Jul; 352(6333):269. PubMed ID: 1906581
    [No Abstract]   [Full Text] [Related]  

  • 24. Federal AIDS policy issues today.
    James JS
    AIDS Treat News; 1997 Aug; (No 276):2-8. PubMed ID: 11364520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversial AIDS drug for US market.
    Barinaga M
    Nature; 1988 Apr; 332(6164):475. PubMed ID: 3357506
    [No Abstract]   [Full Text] [Related]  

  • 26. The fast track toward new AIDS drugs.
    Long K; Long R
    Nurse Pract Forum; 1991 Jun; 2(2):80-1. PubMed ID: 1840952
    [No Abstract]   [Full Text] [Related]  

  • 27. New AIDS programs may improve system.
    Am Fam Physician; 1989 Jan; 39(1):23-4. PubMed ID: 2911957
    [No Abstract]   [Full Text] [Related]  

  • 28. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule.
    Fed Regist; 1992 Apr; 57(73):13244-9. PubMed ID: 10118458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS treatment drugs: clinical trials and compassionate use.
    Levine RJ
    AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
    [No Abstract]   [Full Text] [Related]  

  • 30. AIDS drug brings providers challenge of distribution.
    Taravella S
    Mod Healthc; 1989 Sep; 19(39):38-9. PubMed ID: 10303961
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA warns quality of underground zalcitabine is poor; Roche expands premarketing access programs.
    Clin Pharm; 1992 May; 11(5):385. PubMed ID: 1316252
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS research come to patients' home towns.
    Young FE
    FDA Consum; 1989 May; 23(4):6-7. PubMed ID: 10313019
    [No Abstract]   [Full Text] [Related]  

  • 33. Panel recommends changes to expedite approval of cancer, AIDS drugs.
    Am J Hosp Pharm; 1990 Nov; 47(11):2410, 2413. PubMed ID: 2278248
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA to collect fees from drug companies.
    Minn Med; 1992 Nov; 75(11):46. PubMed ID: 1435650
    [No Abstract]   [Full Text] [Related]  

  • 35. PMA survey cites advances in AIDS research.
    Am Pharm; 1993 Apr; NS33(4):8-9. PubMed ID: 8475858
    [No Abstract]   [Full Text] [Related]  

  • 36. Investigational new drug regs: icing or cake?
    Margolis RE
    Healthspan; 1988 Dec; 5(11):25-6. PubMed ID: 10291398
    [No Abstract]   [Full Text] [Related]  

  • 37. US looking for short cuts to speed drug approval.
    Ezzell C
    Nature; 1988 Aug; 334(6183):553. PubMed ID: 3043232
    [No Abstract]   [Full Text] [Related]  

  • 38. Report of the Second Public Health Service AIDS Prevention and Control Conference. Report of the workgroup on therapeutics.
    Public Health Rep; 1988; 103 Suppl 1(Suppl 1):41-51. PubMed ID: 3147485
    [No Abstract]   [Full Text] [Related]  

  • 39. Generics for AIDS.
    Nat Immunol; 2004 Nov; 5(11):1089. PubMed ID: 15496942
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA reform in Congress: AIDS community absent. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.